Compare CVS Health Corp (CVS) vs GameStop Corp. (GME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs GameStop Corp. — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while GameStop Corp. trades at $25.29 (market cap $12.40B). The key difference: CVS Health Corp is far larger — about 9.1× GameStop Corp.'s market cap, and CVS Health Corp pays a 3.02% dividend while GameStop Corp. pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and GameStop Corp. for 61 Days on average.
| CVS | GME | |
|---|---|---|
Market Cap | $112.49B | $12.40B |
Volume | 8,467,392 | 7,567,400 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $26.53 |
52-Week Low | $70.08 | $17.87 |
Typical Hold Time | 83 Days | 61 Days |
Enterprise Value | $174.83B | $11.67B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
GME trades at $24.58, down 0.73% on the day, with a bullish technical signal from moving averages. The company reported strong profitability with 25.16% net income margin and has beaten earnings expectations in recent quarters. Recent insider buying by CEO Ryan Cohen and directors has driven positive sentiment, with the stock gaining 31% over the past month according to 24/7 Wall Street (2026-09-29).
The outlook remains mixed with solid fundamentals but cautious analyst sentiment. Investment opportunities include strong cash position ($4.77B) and insider confidence, while risks include declining revenue trends and only 16.67% analyst buy ratings. The stock faces execution challenges in its business transformation amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →
